Primary Myofibroblasts Maintain Short-Term Viability following Submucosal Injection in Syngeneic, Immune-Competent

Hassan A Khalil1, Nan Ye Lei1, Wenxian Nie1

  • 1Department of Surgery, UCLA David Geffen School of Medicine, Los Angeles, California, United States of America.

Plos One
|May 29, 2015
PubMed

Related Concept Videos